Navigation Links
World's biggest study on cell phones and brain cancer inconclusive
Date:5/17/2010

This release is available in French.

Montreal, May 17, 2010 The world's biggest investigation on possible links between cell phone use and brain tumours is inconclusive, according to a Canadian scientist who collaborated on the Interphone International Study Group. Jack Siemiatycki, a professor at the University of Montreal and an epidemiologist at the University of Montreal Hospital Research Center, says restricted access to participants compromised the validity of results of the study to be published in the May 18 International Journal of Epidemiology. "The findings of the Interphone Study are ambiguous, surprising and puzzling," he says.

The Interphone International Study Group, which examined whether cellular radio frequencies could be correlated to brain tumours, was coordinated by the International Agency for Research on Cancer. The investigation was led by 21 epidemiologists from Australia, Canada, Denmark, Finland, France, Germany, Israel, Italy, Japan, New Zealand, Norway, Sweden and the United Kingdom. Over 10,000 people took part in the study: cell phone users; non cell phone users; cell phone users who survived brain cancer as well as brain cancer survivors who had never used cell phones.

Paradoxical findings

"If we combine all users and compare them with non-users, the Interphone Study found no increase in brain cancer among users. In fact, surprisingly, we found that when we combine users independently of the amount of use, they had lower brain cancer risks than non-users," says Dr. Siemiatycki, who teaches in the University of Montreal Faculty of Medicine. "However, the study also found heavy users of cell phones appeared to be at a higher risk of brain tumours than non-users."

Why the discrepancy? Simply put, scientists are unsure. Attention has focused on the methodology of the study and, in particular, on the representativeness of the study subjects who participated. With participation rates in the range of 50 percent to 60 percent of eligible subjects, it is possible that the participants did not provide an accurate portrait of cell phone usage among cancer cases and among healthy control subjects. Dr. Siemiatycki argues this problem arose because of constraints imposed on researchers by ethics committees intended to protect potential research subjects.

"Ethics reviews are now so rigid that scientists from Canada, the United States and Europe are losing the kind of access to medical databases and to study subjects that is needed to conduct studies such as this one. Ethics committees increasingly require that researchers work through treating physicians, professionals who are already overworked, to recruit their patients. This may work for clinical research exploring treatment of cancer, in which physicians often have a professional or personal interest, but it does not work for investigations into the causes of cancer. This flawed system can produce biased study results."

Despite the inconclusive results of the Interphone Study, consumers should not panic about possible risks related to cell phones, stresses Dr. Siemiatycki. "If there are risks, they are probably pretty small. Should anyone be concerned about potential dangers of cell phones, they can remedy the issue by using hands-free devices and avoid exposure to radio frequencies around their head."


'/>"/>

Contact: Sylvain-Jacques Desjardins
sylvain-jacques.desjardins@umontreal.ca
514-343-7593
University of Montreal
Source:Eurekalert

Related medicine news :

1. Gunther von Hagens BODY WORLDS of Animals Opening March 19 at the Neunkirchen Zoo
2. Life Ionizers Drums to a New Beat with Julian Pavone, the Worlds Youngest Drummer and Inventor
3. The biggest winners: Summer campers
4. Summit Seeks to Spark Call to Action on Facing Worlds Biggest Challenges
5. Summit seeks to spark call to action on facing worlds biggest challenges
6. Seattle Suttons Healthy Eating Sponsoring The Biggest Loser Chicago Casting Call
7. Young Men and Elderly Women at Biggest Risk for Shoulder Dislocations
8. New developments in nanotechnology tackle the 2 biggest problems associated with chemotherapy
9. AntiBiggestLoser.com; New Blog Takes Aim at Worldwide Reality TV Show, "The Biggest Loser"
10. MyDietShopz.com Announces Biggest Losers Contest - Share Your Story To Inspire Others
11. Biggest Medical Breakthroughs and Milestones of the Last Decade Broadcast on SIRIUS XMs Doctor Radio Channel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... January 23, 2017 , ... ... has launched online education programs and resources at seafoodnutrition.org/programs and seafoodnutrition.org/resources to ... of a seafood-rich diet. These resources have been developed for use by ...
(Date:1/22/2017)... MALO, FRANCE (PRWEB) , ... January 22, 2017 , ... ... Indian Ocean, isolated from the rest of the world with ZANZIBAR MILKY CREAM. Inspired ... Phytocéane used key ingredients like Virgin Coconut Oil and moisturizing vegetal coral to create ...
(Date:1/21/2017)... ... 21, 2017 , ... Caronlab Australia, an Australian company known for health and ... Hilton Head, SC, where it benefited from outstanding meetings with major retail buyers. , ... wellness products. At this trade show, the company had the chance to demonstrate its ...
(Date:1/21/2017)... ... January 21, 2017 , ... Phytocéane invites you ... from the rest of the world with ZANZIBAR SHOWER GEL. Inspired by the beauty ... ingredients, Virgin Coconut Oil and moisturizing vegetal coral to create this gentle, crystal-clear shower ...
(Date:1/21/2017)... ... 2017 , ... In the United States, 20 million women and 10 million ... often feel shame for having struggled with an eating disorder as well as common ... Strong in Life After an Eating Disorder” -- to be featured at this year’s ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... global  anxiety disorders and depression treatment market  is expected to reach a value ... anticipated to drive the market growth in the coming years. Increasing adoption of ... recent years. Continue Reading ... ... ...
(Date:1/23/2017)... NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, ... collaboration agreement with the Children,s Hospital of Philadelphia ... a US key opinion leader in the mitochondrial medicine field. ... ... NeuroVive,s research program, NVP015, in certain experimental disease models. The ...
(Date:1/21/2017)... DUBLIN , Jan 20, 2017 ... "US Clinical Laboratory Testing Market By Type of Test (Tumor, ... Independent), & By Type of Diseases (Tuberculosis, Influenza, Cancer, HIV/AIDS ... ... an attractive destination for healthcare services, market segments, especially clinical ...
Breaking Medicine Technology: